GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
15 hedge funds and large institutions have $355K invested in GeneDx Holdings Warrant in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
61% more capital invested
Capital invested by funds: $220K → $355K (+$135K)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
15% more funds holding
Funds holding: 13 → 15 (+2)
10.95% less ownership
Funds ownership: 10.95% → 0% (-11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$8.26K |
| 2 |
SG
StoneX Group
New York
|
+$5.94K |
| 3 |
VF
Virtu Financial
New York
|
+$957 |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$50 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.07K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$17 |
WGSWW Hedge Fund Activity: Q3 2025 in Review
15 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q3 2025, worth a combined $355K — up 61% from $220K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new WGSWW positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was LMR Partners, adding an estimated $8.26K. The largest seller was UBS Group, cutting an estimated $4.07K.
- 15 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q3 2025, up from 13 in Q2 2025.
- Funds reported $355K of GeneDx Holdings Warrant stock for Q3 2025, up 61% quarter-over-quarter.
- 2 funds opened new GeneDx Holdings Warrant positions in Q3 2025 and 0 closed out, a net change of +2 holders.
- The largest GeneDx Holdings Warrant buyer in Q3 2025 was LMR Partners, an estimated $8.26K added.
- The largest GeneDx Holdings Warrant seller in Q3 2025 was UBS Group, an estimated $4.07K sold.
Based on aggregated 13F filings for Q3 2025.